MacroGenics (MGNX) Financials: Revenue & Earnings

MGNX price $2.48 +0.04 +1.43%

Ticker
MGNX
Price
$2.48
Change
+0.04 +1.43%
Market cap ?
$157.66M
P/E ?
-9.95
Dividend yield ?
0.00%
Beta ?
1.21
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
56
Value
56
Quality
48
Growth
64

Stocklytics score rationale: value 56, quality 48, growth 64.

Financials

2016201720182019202020212022202320242025
865820001555160006012100062024000977640007564300015001800057193000148339000149500000

MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company’s product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for…

Fair value

MGNX fair value Not meaningful. Price $2.48.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare MGNX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-0.10—39.18M
2026-08-130.31-0.0832.83M59.14M
2026-05-13-0.58-0.5720.77M15.24M
2026-03-09-0.22-0.4241.23M34.59M
2025-11-120.27-0.4872.84M27.81M
2025-08-14-0.57-0.5922.24M24.41M
2025-05-13-0.65-0.6113.19M11.77M
2025-03-20-0.25-0.2317.73M34.17M
2024-11-050.900.21110.71M32.69M
2024-08-07-0.89-0.5910.80M20.94M
2024-05-09-0.84-0.679.10M14.86M
2024-03-07-0.75-0.2610.72M32.63M
2023-11-06-0.52-0.1110.40M34.15M
2023-08-09-0.36-0.5213.14M29.74M
2023-05-09-0.611.0724.21M94.31M
2023-03-150.210.1071.18M58.78M
2022-11-03-0.40-0.4941.73M29.28M
2022-08-08-0.67-0.9726.01M14.16M
2022-05-03-1.08-0.8410.67M7.94M
2022-02-24-0.95-0.8313.62M22.23M
2021-11-02-0.86-0.6315.58M37.22M
2021-07-29-0.66-0.2830.37M26.85M
2021-04-29-0.90-0.5316.07M27.95M
2021-02-250.02-0.5851.75M27.76M
2020-11-04-0.66-0.9217.41M25.72M
2020-07-30-0.94-0.8815.64M19.83M
2020-05-05-0.91-1.0112.97M15.34M
2020-02-25-0.62-0.7124.56M41.71M
2019-11-06-0.91-0.9517.98M20.18M
2019-07-31-0.65-0.969.99M16.13M
2019-05-01-0.99-0.959.50M8.39M
2019-02-26-1.06-0.9816.45M15.20M
2018-11-07-0.81-1.2920.62M33.89M
2018-08-07-1.03-1.2018.55M22.31M
2018-05-07-1.34-1.084.50M3.78M
2018-02-272.962.21154.31M113.75M
2017-11-08-1.28-1.011.08M1.40M
2017-08-02-1.14-1.051.08M1.21M
2017-05-03-1.08-0.991.28M1.85M
2017-02-28-1.00-0.869.48M4.54M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-06Bonvini EzioBuy8.00K$2.6020.80K
2026-10-06Bonvini EzioSell8.00K$2.6020.80K
2026-08-19Peters Jeffrey StuartSell31.11K$4.15129.09K
2026-08-17Bonvini EzioBuy40.00K$2.60104.00K
2026-08-17Bonvini EzioSell40.00K$2.60104.00K
2026-05-19O'Brien Federica F.Buy22.00K$4.5299.44K
2026-05-19O'Brien Federica F.Buy3.75K——
2026-05-19Jackson Scott ThomasBuy22.00K$4.5299.44K
2026-05-19Jackson Scott ThomasBuy3.75K——
2026-05-19HEIDEN WILLIAM KBuy22.00K$4.5299.44K
2026-05-19HEIDEN WILLIAM KBuy3.75K——
2026-05-19Liu MargaretBuy22.00K$4.5299.44K
2026-05-19Liu MargaretBuy3.75K——
2026-05-19Chhabra MeenuBuy22.00K$4.5299.44K
2026-05-19Chhabra MeenuBuy3.75K——
2026-05-19HURWITZ EDWARDBuy22.00K$4.5299.44K
2026-05-19HURWITZ EDWARDBuy3.75K——
2026-05-19STUMP DAVID CBuy22.00K$4.5299.44K
2026-05-19STUMP DAVID CBuy3.75K——
2026-05-19Ferrante Karen JeanBuy22.00K$4.5299.44K
2026-05-19Ferrante Karen JeanBuy3.75K——
2026-05-19Koenig ScottBuy22.00K$4.5299.44K
2026-05-19Koenig ScottBuy3.75K——
2026-05-18O'Brien Federica F.Buy3.75K——
2026-05-18O'Brien Federica F.Sell3.75K——
2026-05-18Jackson Scott ThomasBuy3.75K——
2026-05-18Jackson Scott ThomasSell3.75K——
2026-05-18HEIDEN WILLIAM KBuy3.75K——
2026-05-18HEIDEN WILLIAM KSell3.75K——
2026-05-18SIEGEL JAY PHILIPBuy3.75K——
2026-05-18SIEGEL JAY PHILIPSell3.75K——
2026-05-18Liu MargaretBuy3.75K——
2026-05-18Liu MargaretSell3.75K——
2026-05-18Chhabra MeenuBuy3.75K——
2026-05-18Chhabra MeenuSell3.75K——
2026-05-18HURWITZ EDWARDBuy3.75K——
2026-05-18HURWITZ EDWARDSell3.75K——
2026-05-18STUMP DAVID CBuy3.75K——
2026-05-18STUMP DAVID CSell3.75K——
2026-05-18Ferrante Karen JeanBuy3.75K——
2026-05-18Ferrante Karen JeanSell3.75K——
2026-02-15Bonvini EzioBuy16.66K——
2026-02-15Bonvini EzioSell6.43K$1.7111.00K
2026-02-15Bonvini EzioSell16.66K——
2026-02-15Smith Beth AnnBuy1.09K——
2026-02-15Smith Beth AnnSell423$1.71723
2026-02-15Smith Beth AnnSell1.09K——
2026-02-15Karrels JamesBuy15.00K——
2026-02-15Karrels JamesSell5.79K$1.719.90K
2026-02-15Karrels JamesSell15.00K——
2026-02-15Peters Jeffrey StuartBuy13.33K——
2026-02-15Peters Jeffrey StuartSell5.15K$1.718.80K
2026-02-15Peters Jeffrey StuartSell13.33K——
2026-02-15Spitznagel ThomasBuy13.33K——
2026-02-15Spitznagel ThomasSell5.52K$1.719.44K
2026-02-15Spitznagel ThomasSell13.33K——
2026-02-15Risser Eric BlasiusBuy16.66K——
2026-02-15Risser Eric BlasiusSell6.43K$1.7111.00K
2026-02-15Risser Eric BlasiusSell16.66K——
2026-02-15Koenig ScottBuy21.16K——
2026-02-15Koenig ScottSell21.16K——
2026-02-12Bonvini EzioBuy187.50K$1.71320.62K
2026-02-12Bonvini EzioBuy31.25K——
2026-02-12Smith Beth AnnBuy93.75K$1.71160.31K
2026-02-12Smith Beth AnnBuy15.62K——
2026-02-12Karrels JamesBuy150.00K$1.71256.50K
2026-02-12Karrels JamesBuy25.00K——
2026-02-12Peters Jeffrey StuartBuy150.00K$1.71256.50K
2026-02-12Peters Jeffrey StuartBuy25.00K——
2026-02-12Spitznagel ThomasBuy150.00K$1.71256.50K
2026-02-12Spitznagel ThomasBuy25.00K——
2026-02-12Risser Eric BlasiusBuy595.00K$1.711.02M
2026-02-12Risser Eric BlasiusBuy100.00K——
2026-02-08Koenig ScottBuy15.83K——
2026-02-08Koenig ScottSell15.83K——
2026-02-08Spitznagel ThomasBuy9.00K——
2026-02-08Spitznagel ThomasSell3.19K$1.815.77K
2026-02-08Spitznagel ThomasSell9.00K——
2026-02-08Smith Beth AnnBuy1.58K——
2026-02-08Smith Beth AnnSell612$1.811.11K
2026-02-08Smith Beth AnnSell1.58K——
2026-02-08Risser Eric BlasiusBuy11.17K——
2026-02-08Risser Eric BlasiusSell4.31K$1.817.80K
2026-02-08Risser Eric BlasiusSell11.17K——
2026-02-08Peters Jeffrey StuartBuy9.00K——
2026-02-08Peters Jeffrey StuartSell3.47K$1.816.29K
2026-02-08Peters Jeffrey StuartSell9.00K——
2026-02-08Karrels JamesBuy10.00K——
2026-02-08Karrels JamesSell3.86K$1.816.99K
2026-02-08Karrels JamesSell10.00K——
2026-02-08Bonvini EzioBuy11.17K——
2026-02-08Bonvini EzioSell4.31K$1.817.80K
2026-02-08Bonvini EzioSell11.17K——
2026-02-07Spitznagel ThomasBuy6.00K——
2026-02-07Spitznagel ThomasSell2.48K$1.814.50K
2026-02-07Spitznagel ThomasSell6.00K——
2026-02-07Smith Beth AnnBuy2.62K——
2026-02-07Smith Beth AnnSell1.01K$1.811.83K
2026-02-07Smith Beth AnnSell2.62K——
2026-02-07Risser Eric BlasiusBuy6.67K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 129, holders +16 vs prior quarter. Ownership 77.01%.

HolderSharesChangeChange %Value
ARMISTICE CAPITAL, LLC5.01M-1.01M-16.72%23.13M
BLACKROCK, INC.4.68M3.52M+302.29%21.62M
VANGUARD CAPITAL MANAGEMENT LLC2.66M2.16K+0.08%12.27M
RENAISSANCE TECHNOLOGIES LLC2.63M-330.81K-11.16%12.16M
ACADIAN ASSET MANAGEMENT LLC2.54M-1.36K-0.05%11.74M
BANK OF AMERICA CORP /DE/2.49M86.44K+3.60%11.50M
TWO SIGMA INVESTMENTS, LP2.47M-62.13K-2.46%11.39M
MILLENNIUM MANAGEMENT LLC2.37M-420.06K-15.03%10.97M
WASATCH ADVISORS LP2.02M459.18K+29.44%9.33M
RA CAPITAL MANAGEMENT, L.P.1.86M00.00%8.61M
VANGUARD PORTFOLIO MANAGEMENT LLC1.82M611.46K+50.58%8.41M
MACKENZIE FINANCIAL CORP1.64M1.05M+174.94%7.59M
MARSHALL WACE, LLP1.62M-409.31K-20.21%7.47M
GEODE CAPITAL MANAGEMENT, LLC1.58M879.23K+126.09%7.29M
AFFINITY ASSET ADVISORS, LLC1.22M716.61K+143.32%5.62M
D. E. SHAW & CO., INC.1.06M4.57K+0.43%4.91M
JACOBS LEVY EQUITY MANAGEMENT, INC1.00M561.13K+127.20%4.63M
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.1.00M133.16K+15.35%4.62M
STATE STREET CORP863.66K569.98K+194.08%3.99M
GOLDMAN SACHS GROUP INC558.00K284.52K+104.04%2.58M
NORTHERN TRUST CORP516.13K363.85K+238.93%2.38M
VANGUARD FIDUCIARY TRUST CO420.11K80.02K+23.53%1.94M
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.420.00K00.00%1.94M
WALLEYE CAPITAL LLC408.15K332.35K+438.46%1.89M
DIMENSIONAL FUND ADVISORS LP379.33K127.53K+50.65%1.75M

Earnings and financials

MacroGenics, Inc. (MGNX) trades at $2.48, with a market cap of $157.66M and a trailing P/E of -9.95. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
865820001555160006012100062024000977640007564300015001800057193000148339000149500000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

MacroGenics (MGNX) Financials: Revenue & Earnings

MGNX$2.48+0.04 +1.43%

$157.66M

Market Cap

-9.95

P/E

—

Forward P/E

56

Score

Price History